Home > Inhibitors & Agonists > Immunology/Inflammation > Thrombopoietin Receptor (CD110)
Cat. No. Product name CAS No.
DC9938 Lusutrombopag(S-888711) Featured

Lusutrombopag(S-888711) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.

DC40758 Avatrombopag hydrochloride Featured

Avatrombopag (AKR-501) hydrochloride is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag hydrochloride mimics the biological activities of TPO. Avatrombopag hydrochloride increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag hydrochloride is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A.

DC48426 Rafutrombopag

Rafutrombopag is a thrombopoietin (TPO) agonist extracted from patent CN113929668 A.

Page 1 / Total 1 FirstPrevNextLastGoto